Browse studies

Find your next paid study

5 recruiting studies matching your filters

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)

This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination w…

Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+1 more

Estimated

~$10 – $7,500

ECOG-ACRIN Cancer Research GroupNCT04423211

Phase 2

MC230502 Dynamic Investigator Initiated Enterprise (DIVINE) in Prostate Cancer

This phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARP…

Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06378866

Phase 1

ENLIGHTEN: Detection by POSLUMA Following Negative Other PET-PSMA Imaging

This phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emission tomography \[PET\]/computed tomography \[CT\]) for detecting prostate cancer i…

Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma

Estimated

~$10 – $6,250

Northwestern UniversityNCT06813898

Phase 2

A Phase 2 Pragmatic Clinical Trial to Evaluate Administration of Cancer Therapy in the Patients' Homes Versus in Clinic in Black Men With Advanced or Metastatic Prostate Cancer

This phase II trial evaluates the impact of cancer therapy in the patients' home compared to in the clinic on safety, side effects, patient preference, and sat…

Biochemically Recurrent Prostate CarcinomaLocally Advanced Prostate CarcinomaMetastatic Prostate Carcinoma+2 more

Estimated

~$10 – $6,250

Mayo ClinicNCT07073794

Phase 2

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Supervised Exercise Program and Continuous Fitbit Monitoring

This phase II trial studies how well an exercise program and continuous Fitbit monitoring work for managing metabolic syndrome and cardiovascular disease risk …

Biochemically Recurrent Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT05054296